HLB Life Science Co Equity 2024

HLB Life Science Co Aktienanalyse

What does HLB Life Science Co do?

HLB Life Science Co., Ltd. is a leading company in the research, development, and production of biotechnological and pharmaceutical products. The company was founded in 2015 in Seoul, South Korea. Due to the founders' extensive experience in the field of life science and biotechnology, HLB Life Science has quickly established itself as a key player in the industry. HLB Life Science's business model is based on the development and production of innovative biotechnological and pharmaceutical products, as well as collaboration with other companies and research institutions. The aim is to improve people's quality of life by providing effective and safe medications and therapies. The company is divided into various divisions. The Biopharmaceuticals division includes the development and production of biotechnological products such as antibodies, proteins, vaccines, and diagnostics. The Pharmaceuticals division develops and produces advanced drugs in the field of oncology, immunology, and neurology. The Clinical Research Services division offers contract research services in the field of clinical studies to test the effectiveness and safety of drugs. In addition, HLB Life Science Co., Ltd. is also active in the Nutra-Pharmaceuticals division, specializing in the development and production of dietary supplements. HLB Life Science offers various products tailored to the needs of patients. In the field of Biopharmaceuticals, for example, the company produces antibodies and proteins for the treatment of cancer, inflammatory diseases, and infections. Another innovative product is a fully humanized antibody against the hepatitis B virus, which is one of the most common liver diseases. In the Pharmaceuticals field, HLB Life Science offers innovative drugs for the treatment of cancer, autoimmune diseases, and neurological disorders. In the Nutra-Pharmaceuticals field, the company offers dietary supplements based on natural ingredients that can strengthen the immune system. HLB Life Science Co., Ltd. is known in the industry for its innovative strength and excellent research results. The company places great emphasis on continuous research and development to develop innovative products and continuously improve existing products. Due to their outstanding products and services, HLB Life Science has already exported to various countries worldwide and has thus played a significant role in the global market. Looking to the future, HLB Life Science Co., Ltd. continues to focus on innovative research and development, as well as close collaboration with universities and research institutions. The company aims to improve people's health and well-being through effective and safe medications and therapies. HLB Life Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing HLB Life Science Co's Equity

HLB Life Science Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding HLB Life Science Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating HLB Life Science Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

HLB Life Science Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in HLB Life Science Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about HLB Life Science Co stock

What is the equity of HLB Life Science Co this year?

HLB Life Science Co has equity of 0 KRW this year.

What was the equity of HLB Life Science Co compared to the previous year?

The equity of HLB Life Science Co has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of HLB Life Science Co?

A high equity is advantageous for investors of HLB Life Science Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of HLB Life Science Co?

A low equity can be a risk for investors of HLB Life Science Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of HLB Life Science Co affect the company?

An increase in equity of HLB Life Science Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of HLB Life Science Co affect the company?

A reduction in equity of HLB Life Science Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of HLB Life Science Co?

Some factors that can affect the equity of HLB Life Science Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of HLB Life Science Co so important for investors?

The equity of HLB Life Science Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can HLB Life Science Co take to change the equity?

To change equity, HLB Life Science Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does HLB Life Science Co pay?

Over the past 12 months, HLB Life Science Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HLB Life Science Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of HLB Life Science Co?

The current dividend yield of HLB Life Science Co is .

When does HLB Life Science Co pay dividends?

HLB Life Science Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HLB Life Science Co?

HLB Life Science Co paid dividends every year for the past 0 years.

What is the dividend of HLB Life Science Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is HLB Life Science Co located?

HLB Life Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLB Life Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLB Life Science Co from 8/7/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 8/7/2024.

When did HLB Life Science Co pay the last dividend?

The last dividend was paid out on 8/7/2024.

What was the dividend of HLB Life Science Co in the year 2023?

In the year 2023, HLB Life Science Co distributed 0 KRW as dividends.

In which currency does HLB Life Science Co pay out the dividend?

The dividends of HLB Life Science Co are distributed in KRW.